Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histamine succinyl glycine (HSG) is a synthetic hapten used in molecular imaging and pretargeted radioimmunotherapy. It functions as a target for engineered antibodies or antibody fragments, enabling targeted delivery of imaging agents or therapeutics to specific sites, such as tumors. It does not act on endogenous receptors but relies on the specificity of anti-HSG antibodies.
Acts as an artificial target for engineered antibodies or scFv fragments. Facilitates targeted delivery of imaging agents or therapeutics by binding to pre-localized antibodies at the target site (e.g., tumor).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine succinyl glycine (HSG).